Statin deprescribing: a comprehensive review and development of a clinical algorithm for optimal patient management

These findings support statin deprescribing as a safe and effective strategy in selected patients, particularly those with limited life expectancy or multiple comorbidities. Personalised, shared decision-making and multidisciplinary collaboration are essential to guide appropriate deprescribing. Further high-quality research, especially RCTs, is needed to consolidate current evidence and inform future clinical guidelines.